Portable Neuromodulation Stimulator (PoNS®) Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Randomized Controlled Trial.

Korábbi kezelés

• Pre-existing neurological disorders or previous stroke affecting the other hemisphere.
• Concurrent daily use of transcutaneous electric nerve stimulation (TENS) and/or other peripheral stimulation devices (i.e. Bioness®)
• Neurostimulation therapy over the previous 6 months

Más betegség

• Areas of recent bleeding or open wounds; or areas that lack normal sensation on the tongue.
• Diagnosis of dementia or mild cognitive impairment
• Cancer treatment within the past year.
• Chronic infectious diseases.

Egyéb

• Severe arthritis or orthopedic problems that limit passive range of motion.
• Nonremovable metal orthodontic devices.
• Oral health problems.
• Pregnancy.
• Sensitivity to nickel, gold or copper.

• Men and women ≥ 18 and < 85 years of age with a diagnosis ischemic or hemorrhagic stroke at > 6 months since stroke onset event.
• FMA-LE scores < 34 at screening with residual paresis in the lower extremity.
• Able to walk at least 10 feet with or without assistive device.
• FGA score < 23 at screening.
• Montreal Cognitive Assessment 5-min (MoCA 5-min) ≥ 6
• Able to understand, learn and apply instructions on how to operate the PoNS device and perform the rehabilitation exercise program.